You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Paliperidone Extended Release (ER)

Showing 1 - 25 of 8,316
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer Trial in Taichung, Tainan (CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule))

Completed
  • Advanced Cancer
  • CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule)
  • Taichung, Taiwan
  • +1 more
Nov 25, 2022

Hepatic Impairment Trial (20 mg HC-ER)

Completed
  • Hepatic Impairment
  • 20 mg HC-ER
  • (no location specified)
Nov 8, 2022

Healthy Trial (HC-ER + 40% Alcohol, HC-ER + 20% Alcohol, HC-ER + 0% Alcohol)

Completed
  • Healthy
  • HC-ER + 40% Alcohol
  • +2 more
  • (no location specified)
Nov 8, 2022

Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending

Not yet recruiting
  • Bladder Cancer
  • APL-1202 and APL-1501 (Single ascending dose)
  • APL-1202 and APL-1501 (Multiple Ascending dose)
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Sep 11, 2023

Healthy Trial (HC-ER 20 mg capsule (fasted), HC-ER 20 mg capsule (fed))

Completed
  • Healthy
  • HC-ER 20 mg capsule (fasted)
  • HC-ER 20 mg capsule (fed)
  • (no location specified)
Nov 8, 2022

Narcolepsy Type 1, Narcolepsy With Cataplexy Trial (NLS-2, Placebo)

Not yet recruiting
  • Narcolepsy Type 1
  • Narcolepsy With Cataplexy
  • (no location specified)
Jun 21, 2023

Atopic Dermatitis Trial in Hangzhou (TLL-018 extended-release tablet, TLL-018 immediate-release tablet)

Active, not recruiting
  • Atopic Dermatitis
  • TLL-018 extended-release tablet
  • TLL-018 immediate-release tablet
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jul 12, 2023

Post-Traumatic Stress Disorder Trial in Cincinnati (Tramadol, Placebo)

Completed
Has Results
  • Post-Traumatic Stress Disorder
  • Cincinnati, Ohio
    Cincinnati VA Medical Center
Aug 9, 2022

Healthy Trial in Seoul (Acetaminophen)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    H plus Yangji Hospital
Jan 3, 2023

Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)

Not yet recruiting
  • Obesity
  • Naltrexone-Bupropion (NB) Combination
  • Placebo
  • (no location specified)
Oct 18, 2023

Idiopathic Pulmonary Fibrosis Trial (nalbuphine ER, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • nalbuphine ER
  • Placebo
  • (no location specified)
Jul 19, 2023

Healthy Trial in Nottingham (BLU-5937 IR, BLU-5937 ER)

Recruiting
  • Healthy
  • BLU-5937 IR
  • BLU-5937 ER
  • Nottingham, England, United Kingdom
    Quotient Sciences
Oct 4, 2022

Schizophrenia Trial in Worldwide (Paliperidone ER)

Completed
  • Schizophrenia
  • Paliperidone ER
  • Antwerpen, Belgium
  • +235 more
Mar 23, 2021

Lung Carcinoma Trial in Aurora, Buffalo, Vancouver (Extended Release Metformin Hydrochloride)

Recruiting
  • Lung Carcinoma
  • Biopsy
  • +4 more
  • Aurora, Colorado
  • +2 more
Jan 28, 2023

Dyslipidemias Trial in Japan (K-877 ER 0.2 mg/day morning administration (once daily), K-877 ER 0.2 mg/day evening

Completed
  • Dyslipidemias
  • K-877 ER 0.2 mg/day morning administration (once daily)
  • K-877 ER 0.2 mg/day evening administration (once daily)
  • Fukuoka, Japan
  • +13 more
Aug 8, 2022

ADHD, ADHD Trial in Irvine (Methylphenidate Hydrochloride Extended Release Capsules, Placebo)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • ADHD
  • Methylphenidate Hydrochloride Extended Release Capsule
  • Placebo
  • Irvine, California
    University of California, Irvine/Child Development Center
Nov 16, 2022

NIDDM, Obesity Trial in Los Angeles (Metformin Extended Release (ER) Oral Tablet, Placebo)

Not yet recruiting
  • NIDDM
  • Obesity
  • Metformin Extended Release (ER) Oral Tablet
  • Placebo
  • Los Angeles, California
    UCLA Center for Human Nutrition
Jul 17, 2023

ADHD Trial in Boston (Amphetamine Extended Release (ER) Tablet 20 mg)

Completed
  • ADHD
  • Amphetamine Extended Release (ER) Tablet 20 mg
  • Boston, Massachusetts
    Massachusetts General Hospital
Feb 16, 2022

Schizophrenia Schizoaffective Trial (Apo-Methylphenidate ER)

Recruiting
  • Schizophrenia Schizoaffective
  • Apo-Methylphenidate ER
  • Ottawa, Ontario, Canada
    Royal Ottawa Mental Health Centre
Oct 31, 2022

Nalbuphine, Idiopathic Pulmonary Fibrosis, Cough Trial in United Kingdom (Nalbuphine ER, Placebo oral tablet)

Completed
  • Nalbuphine
  • +2 more
  • Nalbuphine ER
  • Placebo oral tablet
  • Antrim, Northern Ireland, United Kingdom
  • +14 more
Oct 3, 2022

Tendinopathy, Chronic Pain, Achilles Tendinopathy Trial in Pittsburgh (Metformin, Placebo)

Not yet recruiting
  • Tendinopathy
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Oct 19, 2023

Dyslipidemias Trial in Kanagawa, Osaka, Tokyo (K-877 ER 0.2 mg/day (once daily), K-877 ER 0.4 mg/day (once daily), K-877 IR 0.2

Completed
  • Dyslipidemias
  • K-877 ER 0.2 mg/day (once daily)
  • +2 more
  • Kanagawa, Japan
  • +10 more
Dec 2, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Houston, Texas
  • +2 more
Aug 17, 2022

Fibromyalgia, Pain, Sleep Trial in Syracuse (cyclobenzaprine ER (AMRIX), )

Terminated
Has Results
  • Fibromyalgia
  • +3 more
  • cyclobenzaprine ER (AMRIX)
  • placebo
  • Syracuse, New York
    SUNY Upstate Medical University
Oct 5, 2021

Multiple Sclerosis Trial in Cairo (Dalfampridine ER, 10 Mg Oral Tablet, Extended Release, Placebo)

Recruiting
  • Multiple Sclerosis
  • Dalfampridine ER, 10 Mg Oral Tablet, Extended Release
  • Placebo
  • Cairo, Egypt
    Ain Shams Univeristy
Feb 15, 2023